SCM
IPSC icon

Sterling Capital Management’s Century Therapeutics IPSC Stock Holding History

Sterling Capital Management’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.09K Buy
+2,484
New +$5.67K ﹤0.01% 2504
2025
Q2 		– Sell
-807
Closed -$384 – 3323
2025
Q1 		$384 Sell
807
-782
-49% -$588 ﹤0.01% 3007
2024
Q4 		$1.6K Buy
1,589
+1,443
+988% +$1.96K ﹤0.01% 2837
2024
Q3 		$250 Buy
+146
New +$286 ﹤0.01% 3077

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Sterling Capital Management's IPSC Position: Q2 2026 in Review

Sterling Capital Management opened a new position in Century Therapeutics (IPSC) in Q2 2026: 2,484 shares worth $6.09K. The stake represents ﹤0.01% of the portfolio and ranks #2504 among its holdings. This is a return to the name: Sterling Capital Management previously reported a position in IPSC as recently as Q1 2025.

Sterling Capital Management first reported a position in IPSC in Q3 2024 and has held it in 4 quarters since. 99 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • Sterling Capital Management held 2,484 shares of Century Therapeutics worth $6.09K as of Q2 2026.
  • Century Therapeutics was a new Sterling Capital Management position in Q2 2026.
  • Century Therapeutics made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2504 holding.
  • Sterling Capital Management first reported a position in Century Therapeutics in Q3 2024 and has held it in 4 quarters since.
  • 99 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.